Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Chemistry
Class Information
Number: 536/24.5
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Carbohydrates or derivatives > Nitrogen containing > N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.) > Dna or rna fragments or modified forms thereof (e.g., genes, etc.) > Nucleic acid expression inhibitors
Description: Fragments of DNA or RNA which are effective inhibitors of transcription or translation.


Patents under this class:

Patent Number Title Of Patent Date Issued
7541453 siRNA targeting aquaporin 4 Jun. 2, 2009
7541344 Modulation of survivin expression Jun. 2, 2009
7538211 Aptamer therapeutics useful in the treatment of complement-related disorders May. 26, 2009
7538095 Genetic inhibition by double-stranded RNA May. 26, 2009
7537894 Methods and kits for monitoring Barrett's metaplasia May. 26, 2009
7534879 Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure May. 19, 2009
7534878 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases May. 19, 2009
7534773 TRPM-2 antisense therapy May. 19, 2009
7534560 Simple catalytic DNA biosensors for ions based on color changes May. 19, 2009
7531649 Aptamers to human epidermal growth factor receptor-3 May. 12, 2009
7531524 Modulators of coagulation factors with enhanced stability May. 12, 2009
7531356 Promoter sequences for corticotropin releasing-factor receptor CRF2.alpha. and method of identifying agents that alter the activity of the promoter sequences May. 12, 2009
7528118 RNAi modulation of ApoB and uses thereof May. 5, 2009
7528117 High efficacy antisense RI.sub..alpha.PKA poly-DNP oligoribonucleotides May. 5, 2009
7528116 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis May. 5, 2009
7524949 Double stranded DNA inhibitor of IRF-1 activity Apr. 28, 2009
7524830 Decoy-containing pharmaceutical compositions and method of using the same Apr. 28, 2009
7524829 Antisense antiviral compounds and methods for treating a filovirus infection Apr. 28, 2009
7524827 Methods and compositions for the inhibition of gene expression Apr. 28, 2009
7524653 Small interfering RNA libraries and methods of synthesis and use Apr. 28, 2009
7521593 Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content Apr. 21, 2009
7521431 Compositions and methods for siRNA inhibition of HIF-1 alpha Apr. 21, 2009
7521191 siRNA targeting connexin 43 Apr. 21, 2009
7517864 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) Apr. 14, 2009
7517644 Method and compositions for cellular reprogramming Apr. 14, 2009
7514550 siRNA targeting myeloid cell leukemia sequence 1 Apr. 7, 2009
7514549 Tumor inhibition by modulating sprouty expression or activity Apr. 7, 2009
7514548 Methods of inhibiting COX-2 Apr. 7, 2009
7514530 Peptide carrier for delivering siRNA into mammalian cells Apr. 7, 2009
7514415 Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides Apr. 7, 2009
7514414 Suppressors of CpG oligonucleotides and methods of use Apr. 7, 2009
7514207 Methods of screening for compounds that decrease phosphorylation of merlin and may be useful in cancer treatment Apr. 7, 2009
7511132 Functional and hyperfunctional siRNA directed against Bcl-2 Mar. 31, 2009
7511131 Antisense modulation of apolipoprotein B expression Mar. 31, 2009
7511025 Compositions and methods for inhibiting the synthesis or expression of MMP-1 Mar. 31, 2009
7510854 Corynebacterium glutamicum genes encoding metabolic pathway proteins Mar. 31, 2009
7507811 siRNA targeting KRAS Mar. 24, 2009
7507810 Compositions and their uses directed to IL-4R alpha Mar. 24, 2009
7507809 RNAi modulation of RSV and therapeutic uses thereof Mar. 24, 2009
7507808 Modulation of endothelial lipase expression Mar. 24, 2009
7507196 Antisense antiviral compounds and methods for treating a filovirus infection Mar. 24, 2009
7504385 si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation Mar. 17, 2009
7501503 Compositions and methods for inhibiting RNase H activity of retroid reverse transcriptase Mar. 10, 2009
7501401 Method for the modulation of function of transcription factors Mar. 10, 2009
7501400 Inhibition of gastric acid production and/or secretion Mar. 10, 2009
7498426 Immunostimulatory oligonucleotide multimers Mar. 3, 2009
7498425 Immunostimulatory oligonucleotide multimers Mar. 3, 2009
7498316 Methods and compositions for treating gain-of-function disorders using RNA interference Mar. 3, 2009
7498315 Methods and compositions for the inhibition of gene expression Mar. 3, 2009
7498313 Large circular target-specific antisense nucleic acid compounds Mar. 3, 2009



 
 
  Recently Added Patents
Conversion of unsaturated chemicals to oligomers
Torenia plant named `DANLOV1201`
Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
Computationally enhanced image recognition system
Steering system having multiple strategies and variable deadzone
Welding wire feeder and connection apparatus
Method for designing a nuclear fuel assembly with damping guide tube
  Randomly Featured Patents
Pyromellitic dimiides of 3,5-dialkyl-4-hydroxyphenylsubstituted amines
Update support in database content management
Gallium phosphide JFET
Pump dispenser having a plunger seal
Fuel additives, their preparation and gasoline engine fuels containing the additives
Method of making an array of electron emitters
Explicit congestion notification for DOCSIS based broadband communication systems
Stair climbing robot
Bone marrow aspiration instrument
Physiological method of improving vision